Chanchal S. Kumar

BioPharmaceuticals R&D, AstraZeneca
Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Author Correction: Integration of whole-body [18F]FDG PET/MRI with non-targeted metabolomics can provide new insights on tissue-specific insulin resistance in type 2 diabetes.

Author Correction: Integration of whole-body [18F]FDG PET/MRI with non-targeted metabolomics can provide new insights on tissue-specific insulin resistance in type 2 diabetes.

Journal: Scientific reports

Published: November 28, 2024

A multi-omics microbiome signature is associated with the benefits of gastric bypass surgery and is differentiated from diet induced weight loss through 2 years of follow-up.

A multi-omics microbiome signature is associated with the benefits of gastric bypass surgery and is differentiated from diet induced weight loss through 2 years of follow-up.

Journal: Mucosal immunology

Published: October 14, 2024

Cardiac biopsies reveal differences in transcriptomics between left and right ventricle in patients with or without diagnostic signs of heart failure.

Cardiac biopsies reveal differences in transcriptomics between left and right ventricle in patients with or without diagnostic signs of heart failure.

Journal: Scientific reports

Published: December 18, 2023

Selecting the right therapeutic target for kidney disease.

Selecting the right therapeutic target for kidney disease.

Journal: Frontiers in pharmacology

Published: June 16, 2022

Antidiabetic activity of Commiphora mukul and Phyllanthus emblica and Computational analysis for the identification of active principles with dipeptidyl peptidase IV inhibitory activity.

Antidiabetic activity of Commiphora mukul and Phyllanthus emblica and Computational analysis for the identification of active principles with dipeptidyl peptidase IV inhibitory activity.

Journal: Indian journal of pharmacology

Published: December 02, 2021

Organ-specific metabolic pathways distinguish prediabetes, type 2 diabetes, and normal tissues.

Organ-specific metabolic pathways distinguish prediabetes, type 2 diabetes, and normal tissues.

Journal: Cell reports. Medicine

Published: May 15, 2021

Artificial intelligence for proteomics and biomarker discovery.

Artificial intelligence for proteomics and biomarker discovery.

Journal: Cell systems

Published: March 04, 2021

Author Correction: Liver macrophages regulate systemic metabolism through non-inflammatory factors.

Author Correction: Liver macrophages regulate systemic metabolism through non-inflammatory factors.

Journal: Nature metabolism

Published: January 20, 2021

A Multi-Omics Approach to Liver Diseases: Integration of Single Nuclei Transcriptomics with Proteomics and HiCap Bulk Data in Human Liver.

A Multi-Omics Approach to Liver Diseases: Integration of Single Nuclei Transcriptomics with Proteomics and HiCap Bulk Data in Human Liver.

Journal: Omics : a journal of integrative biology

Published: March 18, 2020

Metabolomic Profile in HFpEF vs HFrEF Patients.

Metabolomic Profile in HFpEF vs HFrEF Patients.

Journal: Journal of cardiac failure

Published: February 24, 2020

Author Correction: Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes.

Author Correction: Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes.

Journal: Scientific reports

Published: November 29, 2019

A Physiology-Based Model of Bile Acid Distribution and Metabolism Under Healthy and Pathologic Conditions in Human Beings.

A Physiology-Based Model of Bile Acid Distribution and Metabolism Under Healthy and Pathologic Conditions in Human Beings.

Journal: Cellular and molecular gastroenterology and hepatology

Published: November 25, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026